Quantcast

Latest Amides Stories

2014-02-19 23:27:36

As Reuters reported on February 13, Boehringer faces more than 2,000 US lawsuits claiming that Pradaxa caused severe and fatal bleeding. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Pradaxa side effects. San Diego, CA (PRWEB) February 19, 2014 AttorneyOne.com, a recognized authority on law, updated the website recently and now, can...

2014-02-17 23:02:57

ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Valsartan Market, 2009-2018” to its store. Dallas, TX (PRWEB) February 17, 2014 Valsartan (Angiotan or Diovan) is an angiotensin II receptor antagonist (more commonly called an ARB, or angiotensin receptor blocker), with particularly high affinity for the type I (AT1) angiotensin receptor. In December 1996, Valsartan was approved by FDA. In the US, UK and Australia, valsartan is marketed by Novartis...

2014-02-08 23:03:11

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) February 08, 2014 The prescription drug safety center DrugNews.net is announcing new information on the site for patients taking the blood thinner Pradaxa. Amid lawsuits alleging the drug caused internal bleeding injury or death, a judge has scheduled the first Bellwether trial to start this year*. DrugNews was...

2014-02-08 23:01:19

The Firm is evaluating Pradaxa lawsuits on behalf of individual who allegedly suffered serous episodes of Pradaxa bleeding. New York, New York (PRWEB) February 08, 2014 As Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) continue to move forward, Bernstein Liebhard LLP notes that documents recently unsealed in the U.S. District Court, Southern District of Illinois, have shed new light on Boehringer Ingelheim’s marketing of the blood thinning drug. According to a report from The New...

2014-02-04 23:01:40

The Firm is evaluating Pradaxa lawsuits on behalf of clients who allegedly suffered life-threatening and uncontrollable internal hemorrhaging due to their use of the blood thinner. New York, New York (PRWEB) February 04, 2014 The federal judge overseeing thousands of Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) that allege the blood thinner caused patients to suffer life-threatening and uncontrollable internal hemorrhaging has granted a request by plaintiffs to unseal dozens of...

2014-02-04 08:34:36

Robust Clinical Data on Filanesib Presented at ASH Supporting Announced Registration Program BOULDER, Colo., Feb. 4, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter of its fiscal year ending June 30, 2014. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Revenue for the second quarter of fiscal 2014 was $14.1 million, compared to $18.4 million for the same period last year. The decrease was due to license...

2014-01-31 23:33:15

The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news. Visit http://www.DrugRisk.com Chicago, IL (PRWEB) January 31, 2014 The prescription drug safety advocates at DrugRisk.com have added new information for patients taking the blood thinner Pradaxa. A federal judge overseeing lawsuits alleging the drug caused internal bleeding injury or death recently scheduled the first cases for trial*. DrugRisk is a free...

2014-01-29 23:28:36

As Pradaxa Bleeding Lawsuits Mount, FDA Announces Plan for Large Scale Assessment Comparing Pradaxa Bleeding Rates to Warfarin. Columbus, OH (PRWEB) January 29, 2014 The Pradaxa lawyers at Wright & Schulte LLC were pleased with news that the U.S. Food & Drug Administration (FDA) has planned a large scale-assessment comparing Pradaxa bleeding rates to those associated with warfarin. The announcement of the study comes as thousands of Pradaxa lawsuits that allege use of the drug...

2014-01-29 16:28:52

MALVERN, Pa., Jan. 29, 2014 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today confirmed that the United States District Court for the District of Delaware ruled that United States Patent No. 5,464,864, Endo's patent covering frovatriptan, the active ingredient in FROVA(® )(frovatriptan succinate) tablets, is valid and infringed. The Court's decision prevents Mylan from marketing its generic version of FROVA(®) in the U.S. before Endo's patent expires November 8, 2015,...

2014-01-28 23:32:17

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. New York, NY (PRWEB) January 28, 2014 The prescription drug safety advocates at DrugNews.net have added new information to the site for patients taking the blood thinner Pradaxa. The resource center learned the FDA is planning a new study of the drug’s safety* and court records show the number of lawsuits alleging internal...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related